Therefore, our findings that EGFL8 knockdown enhances the spheroid growth of human ovarian cancer cells suggest that EGFL8 plays a critical role in suppressing spheroidogenesis and, consequently, inhibiting the malignant progression of these cells. Here, EGFL8 is linked to ovarian carcinoma.